Legal Representation
Attorney
Sean D. Detweiler
USPTO Deadlines 5 active 5 overdue
| Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
|---|---|---|---|---|---|
|
EXAMINER AMENDMENT
Examiner's Amendment Completed |
CNEA | Oct 27, 2019 | 2080 days overdue | Low | No |
|
EXAMINER AMENDMENT
Examiner's Amendment Completed |
CNEA | Nov 28, 2019 | 2048 days overdue | Low | No |
|
EXAMINER AMENDMENT
Examiner's Amendment Completed |
CNEA | Dec 18, 2019 | 2028 days overdue | Low | No |
|
EXAMINER AMENDMENT
Examiner's Amendment Completed |
CNEA | Dec 28, 2019 | 2018 days overdue | Low | No |
|
OPPOSITION
Notice of Publication |
NPUB | Feb 20, 2020 | 1964 days overdue | Medium | Until Mar 20, 2020 |
Application History
50 events| Date | Code | Type | Description |
|---|---|---|---|
| May 15, 2025 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Apr 7, 2025 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Jun 29, 2024 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Sep 5, 2020 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Aug 14, 2020 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
| Aug 14, 2020 | FIMP | P | FINAL DISPOSITION PROCESSED |
| Jul 7, 2020 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Apr 7, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Jan 21, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jan 21, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jan 17, 2020 | GPNX | P | NOTIFICATION PROCESSED BY IB |
| Jan 1, 2020 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Jan 1, 2020 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Jan 1, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Dec 17, 2019 | ALIE | A | ASSIGNED TO LIE |
| Dec 14, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Dec 13, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Dec 13, 2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Dec 13, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Dec 13, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Dec 3, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Dec 3, 2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Dec 3, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Dec 3, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Nov 13, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Nov 13, 2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Nov 13, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Nov 13, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Oct 31, 2019 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Oct 16, 2019 | CREV | I | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED |
| Oct 12, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Oct 12, 2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Oct 12, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Oct 12, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Aug 16, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Aug 16, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Aug 8, 2019 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Jul 26, 2019 | CRCV | M | CORRECTION TRANSACTION RECEIVED FROM IB |
| Jul 10, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Jul 10, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Jun 28, 2019 | RFNT | P | REFUSAL PROCESSED BY IB |
| Jun 27, 2019 | CHLD | M | CHANGE OF OWNER RECEIVED FROM IB |
| Jun 3, 2019 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Jun 3, 2019 | RFRR | P | REFUSAL PROCESSED BY MPU |
| May 12, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| May 11, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
| May 7, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| May 3, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| May 3, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
| May 2, 2019 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
Detailed Classifications
Class 009
Downloadable computer software for transmitting, analyzing and generating reports; downloadable Computer software for data processing in the field of healthcare, biomedical research, and clinical trial data; Downloadable computer software for providing, analyzing and generating reports in the field of healthcare, biomedical research, and clinical trial data; Downloadable computer software for data processing; Downloadable computer programs and computer operating systems for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information; Downloadable computer programs and computer operating systems for the conversion, analysis, processing, storage and transmission of artificial intelligence; Downloadable artificial intelligence and machine learning software for statistical analysis, consultancy and reporting; Downloadable software for analytics in the field of public health, healthcare, pharmaceuticals, biotechnology, biomedical research and development, clinical trials as well as post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; Downloadable software for data linkage, discovery, and de-identification used in the fields of healthcare, biomedical research, and clinical trial data for the provision of medical services, public health services and healthcare services; Downloadable computer software for database integration; Downloadable computer software for creating searchable databases of information and data; Downloadable computer software featuring an electronic computer database for linking, viewing, and de-identifying healthcare and healthcare related data used in the field of healthcare, biomedical research, and clinical trial data; Downloadable computer software for accessing data and information related to healthcare services, patient medical information and clinical trial data and for controlling and managing data and information related to healthcare services, patient medical information and clinical trial data; none of the foregoing directly related to video surveillance or video based security apparatus
Class 035
Advertising; business management; business administration; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; business data analysis and professional business consultancy services regarding statistics for biomedical research, healthcare institutions and healthcare professionals, based on artificial intelligence and machine learning; business analysis and statistical analysis of healthcare data, biomedical research and clinical trial data; systematization and compilation of data in computer databases; compilation of information into computer databases for research and analysis purposes in the fields of public health, healthcare, biomedicine, biotechnology, pharmaceuticals, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research, pharmacoepidemiological research and research evaluating epidemiological outcomes; professional business analysis, business consultancy and statistical analysis for business purposes in the fields of public health, healthcare, pharmaceuticals, biotechnology, biomedical research and developments, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research, pharmacoepidemiological research and research evaluating epidemiological outcomes
Class 042
Scientific and technological services, namely, medical research and scientific research, chemical analysis in the healthcare and biomedical field; Scientific research; Chemical analysis for industrial purposes; Biomedical research services; Design and development of computer software; Cloud computing featuring software for de-identifying, linking, and analyzing data used in the field of healthcare, biomedical research, and clinical trial data; Scientific data processing analysis services; Pharmaceutical and biomedical research services, conducting clinical trials for others, post-authorization research for the marketing of medicines and commercial post-launching of medicines, epidemiological research, pharmacoepidemiological research and research evaluating epidemiological outcomes; Providing temporary use of non-downloadable software applications accessible via a web site for de-identifying, linking, and analyzing data used in the field of healthcare, biomedical research, and clinical trial data regarding analytics in the fields of public health, healthcare, pharmaceuticals, biomedical research and clinical trial data; Providing temporary use of non-downloadable software applications accessible via a web site for de-identifying, linking, and analyzing data used in the field of healthcare, biomedical research, and clinical trial data regarding information in the fields of public health, healthcare, pharmaceuticals, biomedical research and clinical trials; Providing temporary use of non-downloadable software applications accessible via a web site for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information; Providing temporary use of non-downloadable software applications accessible via a web site for de-identifying, linking, and analyzing data used in the field of healthcare, biomedical research, and clinical trial data regarding data in the fields of public health, healthcare, pharmaceuticals, biomedical research, patient data, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research and pharmacoepidemiological research; Providing technological online information in the fields of public health, healthcare, pharmaceuticals, patient data, biomedical research, clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines from a computer database or the Internet; Providing scientific online information online in the fields of public health, healthcare, pharmaceuticals, patient data, biomedical research, clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines from a computer database or the Internet; Providing scientific research information in the field of biomedicine, clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; Scientific analysis in the field of scientific data relating to biomedical research and clinical trials; Research and analysis services in the scientific fields of artificial intelligence and machine learning analytics for biomedical research and healthcare institutions
Additional Information
Design Mark
The mark consists of stylized lowercase blue "D" inside of a blue hexagon which has a break at the top right. Above the stylized lowercase blue "D" are three blue squares. Below the hexagon image is the wording "DATAVANT" in black text. The mark is displayed on a white background which is not claimed as a feature of the mark.
Color Claim
The colors black and blue are claimed as a feature of the mark.
Classification
International Classes
009
035
042